In-depth examination into Elsan's plans to acquire Hexagone Santé Méditerranée


Elsan notified the Autorité de la concurrence of its plans to take exclusive control of Hexagone Santé Méditerranée (HSM).

The parties to the transaction are especially active in the diagnosis and hospital care markets in the Gard département at numerous healthcare facilities (hospitals and clinics).

After an initial examination phase (Phase 1), the Autorité considered that there was a serious suspicion of harm to competition on the healthcare and diagnosis markets and that the proposed commitments failed to sufficiently meet competition requirements, which justified an in-depth examination of the transaction (Phase 2).

Print the page